Table III.
Cell type | Type of stress | Test subject | Mediators | Impact | (Refs.) |
---|---|---|---|---|---|
Oocyte | CUS | Mice | HPA axis | Increased follicle atresia with suppressed GDF9 expression | (84) |
CRS | Mice | HPA axis | Increased abnormal bipolar spindle rates; reduced the expression of CCNB1; increased meiotic arrest failure of oocytes by inhibition of the cAMP pathway; overactivation of primordial follicles due to activation of the PI3K/AKT pathway | (20,21,93) | |
N/A | Rats | NE | Decreased ovarian sympathetic activity decreases KISS1 levels and increases FSHR expression and follicle growth | (177) | |
Injection of cortisol | Mice | Cortisol | Impaired oocyte development and mitochondrial membrane potential | (128,161) | |
Granulosa | CUS | Mice | HPA axis | Increased apoptosis due to the ROS accumulation and MAPK pathway activation | (85) |
CRS | Mice | HPA axis | Increased apoptosis via activating the Fas/FasL and TNFα system | (97,103)) | |
N/A | Humans | NE | Induced generation of ROS in granulosa cells | (178) | |
Injection of cortisol | Mice | Cortisol | Decreased expression of IGF1 and BDNFl increased apoptosis | (128,161) | |
N/A | Rats | NE | Activation of TGFβ-SMAD7 pathway and apoptosis | (179) |
CUS, chronic unpredictable stress; HPA, hypothalamic-pituitary-adrenal; GDF9, growth differentiation factor 9; CRS, chronic restraint stress; CCNB1, cyclin B1; cAMP, cyclic AMP; KISS, kisspeptin; FSHR, follicle-stimulating hormone receptor; ROS, reactive oxygen species; NE, norepinephrine; IGF1, insulin-like growth factor 1; BDNF, brain-derived neurotrophic factor; TGFβ, transforming growth factor β; ET-AR, endothelin-receptor type A.